{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:42:01Z","timestamp":1777477321307,"version":"3.51.4"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"DOI":"10.1007\/s00280-026-04869-x","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T02:26:59Z","timestamp":1773455219000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of high-dose methotrexate infusion duration on 48-hour drug levels and toxicity in children with acute lymphoblastic leukaemia: a quality-of-care study"],"prefix":"10.1007","volume":"96","author":[{"given":"Soumya Jyoti","family":"Raha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prateek","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amita","family":"Trehan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,14]]},"reference":[{"issue":"3","key":"4869_CR1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1053\/j.seminhematol.2013.06.007","volume":"50","author":"CH Pui","year":"2013","unstructured":"Pui CH, Evans WE (2013) A 50-year journey to cure childhood acute lymphoblastic leukemia. Semin Hematol 50(3):185\u2013196","journal-title":"Semin Hematol"},{"issue":"5","key":"4869_CR2","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1592\/phco.25.5.748.63584","volume":"25","author":"E Mantadakis","year":"2005","unstructured":"Mantadakis E, Cole PD, Kamen BA (2005) High-dose methotrexate in acute lymphoblastic leukemia: where is the evidence for its continued use? Pharmacotherapy 25(5):748\u2013755","journal-title":"Pharmacotherapy"},{"issue":"12","key":"4869_CR3","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1634\/theoncologist.2015-0164","volume":"21","author":"SC Howard","year":"2016","unstructured":"Howard SC, McCormick J, Pui CH, Buddington RK, Harvey RD (2016) Preventing and managing toxicities of high-dose methotrexate. Oncologist 21(12):1471\u20131482","journal-title":"Oncologist"},{"issue":"6","key":"4869_CR4","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1634\/theoncologist.11-6-694","volume":"11","author":"BC Widemann","year":"2006","unstructured":"Widemann BC, Adamson PC (2006) Understanding and managing methotrexate nephrotoxicity. Oncologist 11(6):694\u2013703","journal-title":"Oncologist"},{"issue":"7","key":"4869_CR5","doi-asserted-by":"publisher","first-page":"e412","DOI":"10.1097\/MPH.0000000000000044","volume":"36","author":"M Dhamija","year":"2014","unstructured":"Dhamija M, Kapoor G, Juneja A (2014) Infusional chemotherapy and medication errors in a tertiary care pediatric cancer unit in a resource-limited setting. J Pediatr Hematol Oncol 36(7):e412-415","journal-title":"J Pediatr Hematol Oncol"},{"key":"4869_CR6","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) | Protocol Development | CTEP [Internet]. [cited 2025 Jun 16]. Available from: https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm"},{"issue":"6","key":"4869_CR7","volume":"12","author":"AR Chen","year":"2020","unstructured":"Chen AR, Wang YM, Lin M, Kuo DJ (2020) High-dose methotrexate in pediatric acute lymphoblastic leukemia: predictors of delayed clearance and the effect of increased hydration rate on methotrexate clearance. Cureus 12(6):e8674","journal-title":"Cureus"},{"issue":"13","key":"4869_CR8","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1200\/JCO.2010.32.5340","volume":"29","author":"TS Mikkelsen","year":"2011","unstructured":"Mikkelsen TS, Sparreboom A, Cheng C, Zhou Y, Boyett JM, Raimondi SC et al (2011) Shortening infusion time for high-dose methotrexate alters antileukemic effects: a randomized prospective clinical trial. J Clin Oncol 29(13):1771\u20131778","journal-title":"J Clin Oncol"},{"issue":"3","key":"4869_CR9","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1007\/s12288-019-01245-z","volume":"36","author":"P Mandal","year":"2020","unstructured":"Mandal P, Samaddar S, Chandra J, Parakh N, Goel M (2020) Adverse effects with intravenous methotrexate in children with acute lymphoblastic leukemia\/lymphoma: a retrospective study. Indian J Hematol Blood Transfus 36(3):498\u2013504","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"Supplement 1","key":"4869_CR10","first-page":"4132","volume":"130","author":"K Narita","year":"2017","unstructured":"Narita K, Kobayashi H, Abe Y, Takeuchi M, Matsue K (2017) Evaluation of risk factors and survival effect of delayed excretion of high-dose methotrexate in patients with leukemia and lymphoma. Blood 130(Supplement 1):4132","journal-title":"Blood"},{"issue":"4","key":"4869_CR11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.5414\/CNP64315","volume":"64","author":"H Izzedine","year":"2005","unstructured":"Izzedine H, Launay-Vacher V, Karie S, Caramella C, de Person F, Deray G (2005) Is low-dose methotrexate nephrotoxic? Case report and review of the literature. Clin Nephrol 64(4):315\u2013319","journal-title":"Clin Nephrol"},{"issue":"1","key":"4869_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phoj.2018.01.003","volume":"3","author":"P Tiwari","year":"2018","unstructured":"Tiwari P, Ganesan P, Radhakrishnan V, Arivazhagan R, Ganesan TS, Dhanushkodi M et al (2018) Prospective evaluation of the toxicity profile, and predictors of toxicity of high dose methotrexate in patients of acute lymphoblastic leukemia\/lymphoma. Pediatric Hematology Oncology Journal 3(1):1\u20135","journal-title":"Pediatric Hematology Oncology Journal"},{"issue":"12","key":"4869_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27241","volume":"65","author":"K Vaishnavi","year":"2018","unstructured":"Vaishnavi K, Bansal D, Trehan A, Jain R, Attri SV (2018) Improving the safety of high-dose methotrexate for children with hematologic cancers in settings without access to MTX levels using extended hydration and additional leucovorin. Pediatr Blood Cancer 65(12):e27241","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"4869_CR14","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/pbc.24081","volume":"59","author":"G Kapoor","year":"2012","unstructured":"Kapoor G, Sinha R, Abedin S (2012) Experience with high dose methotrexate therapy in childhood acute lymphoblastic leukemia in a tertiary care cancer centre of a developing country. Pediatr Blood Cancer 59(3):448\u2013453","journal-title":"Pediatr Blood Cancer"},{"issue":"35","key":"4869_CR15","doi-asserted-by":"publisher","first-page":"5972","DOI":"10.1200\/JCO.2008.20.4156","volume":"27","author":"LR Trevi\u00f1o","year":"2009","unstructured":"Trevi\u00f1o LR, Shimasaki N, Yang W, Panetta JC, Cheng C, Pei D et al (2009) Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects. J Clin Oncol 27(35):5972\u20135978","journal-title":"J Clin Oncol"},{"issue":"26","key":"4869_CR16","doi-asserted-by":"publisher","first-page":"5145","DOI":"10.1182\/blood-2013-01-480335","volume":"121","author":"S Radtke","year":"2013","unstructured":"Radtke S, Zolk O, Renner B, Paulides M, Zimmermann M, M\u00f6ricke A et al (2013) Germline genetic variations in methotrexate candidate genes are associated with pharmacokinetics, toxicity, and outcome in childhood acute lymphoblastic leukemia. Blood 121(26):5145\u20135153","journal-title":"Blood"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-026-04869-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-026-04869-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-026-04869-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T15:01:56Z","timestamp":1773500516000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00280-026-04869-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,14]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4869"],"URL":"https:\/\/doi.org\/10.1007\/s00280-026-04869-x","relation":{},"ISSN":["1432-0843"],"issn-type":[{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,14]]},"assertion":[{"value":"7 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author(s) declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"Ethical approval for this study was obtained from the Ethics Committee of the Research Department at PGIMER, Chandigarh (INT\/IEC\/2024\/SPL-967). The study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki. All participants were informed about the purpose of the study, assured of confidentiality, and provided written consent prior to participation. Participation was voluntary, and respondents could withdraw at any time without consequence","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Observational study","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"24"}}